Log in

NASDAQ:STAA - STAAR Surgical Stock Price, Forecast & News

+0.27 (+0.73 %)
(As of 12/8/2019 11:15 AM ET)
Today's Range
Now: $37.32
50-Day Range
MA: $33.77
52-Week Range
Now: $37.32
Volume216,536 shs
Average Volume360,895 shs
Market Capitalization$1.66 billion
P/E Ratio133.29
Dividend YieldN/A
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. Read More…

Industry, Sector and Symbol

Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
Current SymbolNASDAQ:STAA



Sales & Book Value

Annual Sales$123.95 million
Cash Flow$0.34 per share
Book Value$3.00 per share


Net Income$4.97 million


Market Cap$1.66 billion
Next Earnings Date2/20/2020 (Estimated)

Receive STAA News and Ratings via Email

Sign-up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) issued its quarterly earnings results on Wednesday, October, 30th. The medical instruments supplier reported $0.05 earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of $0.05. The medical instruments supplier earned $39.06 million during the quarter, compared to the consensus estimate of $37.50 million. STAAR Surgical had a return on equity of 13.84% and a net margin of 6.15%. View STAAR Surgical's Earnings History.

When is STAAR Surgical's next earnings date?

STAAR Surgical is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for STAAR Surgical.

What price target have analysts set for STAA?

2 equities research analysts have issued 12-month price objectives for STAAR Surgical's stock. Their forecasts range from $45.00 to $46.00. On average, they expect STAAR Surgical's share price to reach $45.50 in the next year. This suggests a possible upside of 21.9% from the stock's current price. View Analyst Price Targets for STAAR Surgical.

What is the consensus analysts' recommendation for STAAR Surgical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for STAAR Surgical.

Has STAAR Surgical been receiving favorable news coverage?

News stories about STAA stock have trended extremely negative recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. STAAR Surgical earned a daily sentiment score of -5.0 on InfoTrie's scale. They also gave news articles about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for STAAR Surgical.

Are investors shorting STAAR Surgical?

STAAR Surgical saw a increase in short interest during the month of November. As of November 15th, there was short interest totalling 3,340,000 shares, an increase of 5.0% from the October 31st total of 3,180,000 shares. Based on an average trading volume of 327,900 shares, the days-to-cover ratio is presently 10.2 days. Currently, 7.6% of the shares of the stock are sold short. View STAAR Surgical's Current Options Chain.

Who are some of STAAR Surgical's key competitors?

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Vanda Pharmaceuticals (VNDA), Xilinx (XLNX), NVIDIA (NVDA), TransEnterix (TRXC), Rockwell Medical (RMTI), Splunk (SPLK), Zynerba Pharmaceuticals (ZYNE), Walt Disney (DIS), Adobe (ADBE) and Cerus (CERS).

Who are STAAR Surgical's key executives?

STAAR Surgical's management team includes the folowing people:
  • Ms. Caren L. Mason, CEO, Pres & Director (Age 65)
  • Ms. Deborah J. Andrews, Chief Financial Officer (Age 62)
  • Dr. Keith Holliday, Chief Technology Officer (Age 56)
  • Mr. Samuel J. Gesten, Chief Legal Officer & Corp. Sec. (Age 57)
  • Mr. Hans-Martin Blickensdoerfer, Sr. VP of Commercial Operations, Direct Markets- Europe & China (Age 54)

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by many different of institutional and retail investors. Top institutional shareholders include State Street Corp (2.73%), TimesSquare Capital Management LLC (2.24%), Defender Capital LLC. (1.31%), Kornitzer Capital Management Inc. KS (0.64%), Jericho Capital Asset Management L.P. (0.47%) and Quantum Capital Management (0.38%). Company insiders that own STAAR Surgical stock include Broadwood Partners, LP, Caren L Mason, Deborah J Andrews, Graydon C Hansen, Keith Holliday, Samuel J Gesten, Scott D Barnes and William P Wall. View Institutional Ownership Trends for STAAR Surgical.

Which major investors are selling STAAR Surgical stock?

STAA stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, SG Americas Securities LLC, Squarepoint Ops LLC, TimesSquare Capital Management LLC, Cadence Capital Management LLC, Defender Capital LLC., State Street Corp and Kornitzer Capital Management Inc. KS. Company insiders that have sold STAAR Surgical company stock in the last year include Caren L Mason, Deborah J Andrews, Graydon C Hansen, Keith Holliday, Samuel J Gesten and Scott D Barnes. View Insider Buying and Selling for STAAR Surgical.

Which major investors are buying STAAR Surgical stock?

STAA stock was acquired by a variety of institutional investors in the last quarter, including Jericho Capital Asset Management L.P., State of New Jersey Common Pension Fund D, California Public Employees Retirement System, Stifel Financial Corp, Commonwealth Equity Services LLC, Envestnet Asset Management Inc., Dfpg Investments Inc. and BBVA USA Bancshares Inc.. View Insider Buying and Selling for STAAR Surgical.

How do I buy shares of STAAR Surgical?

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $37.32.

How big of a company is STAAR Surgical?

STAAR Surgical has a market capitalization of $1.66 billion and generates $123.95 million in revenue each year. The medical instruments supplier earns $4.97 million in net income (profit) each year or $0.28 on an earnings per share basis. STAAR Surgical employs 475 workers across the globe.View Additional Information About STAAR Surgical.

What is STAAR Surgical's official website?

The official website for STAAR Surgical is http://www.staar.com/.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]

MarketBeat Community Rating for STAAR Surgical (NASDAQ STAA)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  214 (Vote Outperform)
Underperform Votes:  291 (Vote Underperform)
Total Votes:  505
MarketBeat's community ratings are surveys of what our community members think about STAAR Surgical and other stocks. Vote "Outperform" if you believe STAA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STAA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Featured Article: Trading Strategy

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel